Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Titel:
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Auteur:
Costa, Luciano J. Davies, Faith E. Monohan, Gregory P. Kovacsovics, Tibor Burwick, Nicholas Jakubowiak, Andrzej Kaufman, Jonathan L. Hong, Wan-Jen Dail, Monique Salem, Ahmed Hamed Yang, Xiaoqing Masud, Abdullah A. Munasinghe, Wijith Ross, Jeremy A. Bueno, Orlando F. Kumar, Shaji K. Stadtmauer, Edward A.